UK Markets close in 1 hr

The Biotech Growth Trust Plc - Result of AGM

  • Oops!
    Something went wrong.
    Please try again later.
·3-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

THE BIOTECH GROWTH TRUST PLC

(the “Company”)

Results of the Annual General Meeting

The Board is pleased to announce that at the Annual General Meeting (AGM) of the Company held on Tuesday, 19 July 2022 all resolutions as detailed below were duly passed by shareholders on a poll.

Resolutions

Votes For

%

Votes Against

%

Total Votes Cast

Votes
Withheld*

Ordinary Business

1.To accept the audited financial statements and the Report of the Directors for the year ended 31 March 2022.

13,474,466

92.61%

1,074,666

7.39%

14,549,132

2,596

2.To approve the Directors’ Remuneration Report for the year ended 31 March 2022.

14,509,767

99.76%

34,232

0.24%

14,543,999

7,729

3.To elect Mr Roger Yates as a Director of the Company.

14,534,959

99.90%

13,850

0.10%

14,548, 809

2,919

4.To re-elect Dr Nicki Shepherd as a Director of the Company.

14,413,348

99.07%

135,461

0.93%

14,548,809

2,919

5.To re-elect Mr Steve Bates as a Director of the Company.

14,411,834

99.06%

137,306

0.94%

14,549,140

2,588

6.To re-elect The Rt Hon Lord Willetts as a Director of the Company.

14,022,147

96.38%

527,096

3.62%

14,549,243

2,485

7.To re-elect Mrs Julia Le Blan as a Director of the Company.

14,410,635

99.04%

139,003

0.96%

14,549,638

2,090

8.To re-elect Mr Geoff Hsu as a Director of the Company.

13,465,835

92.56%

1,082,910

7.44%

14,548,745

2,983

9.To re-appoint BDO LLP as auditor and to authorise the Audit Committee to determine their remuneration.


14,533,604


99.89%


15,880


0.11%


14,549,484


2,244

Special Business

10.To authorise the Directors to allot securities in the Company.

14,524,493

99.84%

22,980

0.16%

14,547,473

4,255

11#. To disapply the rights of pre-emption in relation to the allotment of securities.

14,506,576

99.72%

40,848

0.28%

14,547,424

4,304

12#. To authorise the Company to make market purchases of Ordinary shares in the Company.

14,537,072

99.94%

8,406

0.06%

14,545,478

6,250

13#. That the Directors be permitted to hold General Meetings (excluding the AGM) on not less than 14 clear days’ notice.

14,462,258

99.40%

86,586

0.60%

14,548,844

2,884

# - Special Resolution

* Please note that a ‘vote withheld’ is not a vote in law and is not counted in the calculation of the proportion of votes ‘For’ and ‘Against’ a resolution.

Any proxy votes which are at the discretion of the Chairman have been included in the "For" total.

At the date of the AGM, the total number of Ordinary shares of 25p each in issue and the total number of voting rights was 40,921,729.

The proxy voting figures will shortly also be available on the Company’s website at www.biotechgt.com

In accordance with Listing Rule 9.6.2, the full text of the special business resolutions passed has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. The special business resolutions will additionally be filed at Companies House.

19 July 2022

For further information please contact:

Katherine Manson

Frostrow Capital LLP – Company Secretary

020 3709 8734

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting